News
Oss, the Netherlands – 9 March 2023 The project looked for compounds that stop the virus’s spike protein from binding
9 March 2023
Menu
Menu
Oss, the Netherlands – 9 March 2023 The project looked for compounds that stop the virus’s spike protein from binding
Assay Development Fund now available for your early drug discovery project
Oss, the Netherlands – 20 February 2023 Pivot Park Screening Centre is excited to take the coordinating role in this
Mass Spectrometry methods in High Throughput Screening
Maaike Bras, scientist assay development at Pivot Park Screening Centre, joined in the Lab of the Future series from SLAS
We have been awarded the ISO 9001:2015 & ISO/IEC 27001:2013 certification
Oss, the Netherlands – 4 January 2023 It’s official! After all our hard work we have been awarded the prestigious
Oss, the Netherlands – 9 December 2022 With the world still in the grasp of continued Covid-19 infections and the
Pivot Park Screening Centre (PPSC) celebrates its 10-year anniversary
Oss, the Netherlands – 15 November 2022 Today Pivot Park Screening Centre celebrates its 10-year anniversary. PPSC builds on the
Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs
Utrecht, 14 April 2022 – The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical
Label-free Mass Spectrometry ultra-HighThroughput Screening
A game-changer in small molecule lead discovery. Pivot Park Screening Centre (PPSC) is the first contract research organization (CRO) that
Oss, the Netherlands and Mannheim, Germany – 21 February 2022 PPSC and CeMOS have formed a strategic partnership to provide
Collaboration Pivot Park Screening Centre and Radboud Summer school
Pivot Park Screening Centre is one of the creators of the ‘Preclinical Drug Discovery’ Radboud Summer School hosted by Pivot
Developing the perfect high throughput biophysical assay using MS
Sometime ago I was inspired by a publication from Simon et al. (SLAS Discovery, 2020)* about possibilities to develop a
INFOGRAPHIC: Label free mass spec uHTS
Our automated ultra-High-Throughput Screening (uHTS) platform is expanded with the rapifleX® MALDI PharmaPulse® (Bruker AG) along with CyBio Well Vario system (Analytik Jena AG).
Subscribe to our newsletter
Pivot Park – Banting Building (RE2423)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands
